220 related articles for article (PubMed ID: 18448868)
1. SDF-1/CXCR4 and VLA-4 interaction regulates homing in Waldenstrom macroglobulinemia.
Ngo HT; Leleu X; Lee J; Jia X; Melhem M; Runnels J; Moreau AS; Burwick N; Azab AK; Roccaro A; Azab F; Sacco A; Farag M; Sackstein R; Ghobrial IM
Blood; 2008 Jul; 112(1):150-8. PubMed ID: 18448868
[TBL] [Abstract][Full Text] [Related]
2. Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-dependent adhesion to fibronectin and VCAM-1 on bone marrow hematopoietic progenitor cells.
Hidalgo A; Sanz-Rodríguez F; Rodríguez-Fernández JL; Albella B; Blaya C; Wright N; Cabañas C; Prósper F; Gutierrez-Ramos JC; Teixidó J
Exp Hematol; 2001 Mar; 29(3):345-55. PubMed ID: 11274763
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk between CXCR4/stromal derived factor-1 and VLA-4/VCAM-1 pathways regulates neutrophil retention in the bone marrow.
Petty JM; Lenox CC; Weiss DJ; Poynter ME; Suratt BT
J Immunol; 2009 Jan; 182(1):604-12. PubMed ID: 19109194
[TBL] [Abstract][Full Text] [Related]
4. Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-mediated multiple myeloma cell adhesion to CS-1/fibronectin and VCAM-1.
Sanz-Rodríguez F; Hidalgo A; Teixidó J
Blood; 2001 Jan; 97(2):346-51. PubMed ID: 11154207
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma.
Alsayed Y; Ngo H; Runnels J; Leleu X; Singha UK; Pitsillides CM; Spencer JA; Kimlinger T; Ghobrial JM; Jia X; Lu G; Timm M; Kumar A; Côté D; Veilleux I; Hedin KE; Roodman GD; Witzig TE; Kung AL; Hideshima T; Anderson KC; Lin CP; Ghobrial IM
Blood; 2007 Apr; 109(7):2708-17. PubMed ID: 17119115
[TBL] [Abstract][Full Text] [Related]
6. Mobilization of myeloma cells involves SDF-1/CXCR4 signaling and downregulation of VLA-4.
Gazitt Y; Akay C
Stem Cells; 2004; 22(1):65-73. PubMed ID: 14688392
[TBL] [Abstract][Full Text] [Related]
7. Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): importance for interactions with the stromal microenvironment and specific targeting.
Kurtova AV; Tamayo AT; Ford RJ; Burger JA
Blood; 2009 May; 113(19):4604-13. PubMed ID: 19228923
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia promotes dissemination and colonization in new bone marrow niches in Waldenström macroglobulinemia.
Muz B; de la Puente P; Azab F; Ghobrial IM; Azab AK
Mol Cancer Res; 2015 Feb; 13(2):263-72. PubMed ID: 25232031
[TBL] [Abstract][Full Text] [Related]
9. CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion.
Libura J; Drukala J; Majka M; Tomescu O; Navenot JM; Kucia M; Marquez L; Peiper SC; Barr FG; Janowska-Wieczorek A; Ratajczak MZ
Blood; 2002 Oct; 100(7):2597-606. PubMed ID: 12239174
[TBL] [Abstract][Full Text] [Related]
10. Dissecting the role of the CXCL12/CXCR4 axis in acute myeloid leukaemia.
Ladikou EE; Chevassut T; Pepper CJ; Pepper AG
Br J Haematol; 2020 Jun; 189(5):815-825. PubMed ID: 32135579
[TBL] [Abstract][Full Text] [Related]
11. Migration of human umbilical cord blood mesenchymal stem cells mediated by stromal cell-derived factor-1/CXCR4 axis via Akt, ERK, and p38 signal transduction pathways.
Ryu CH; Park SA; Kim SM; Lim JY; Jeong CH; Jun JA; Oh JH; Park SH; Oh WI; Jeun SS
Biochem Biophys Res Commun; 2010 Jul; 398(1):105-10. PubMed ID: 20558135
[TBL] [Abstract][Full Text] [Related]
12. Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells.
Burger M; Glodek A; Hartmann T; Schmitt-Gräff A; Silberstein LE; Fujii N; Kipps TJ; Burger JA
Oncogene; 2003 Nov; 22(50):8093-101. PubMed ID: 14603250
[TBL] [Abstract][Full Text] [Related]
13. Effects of the chemokine stromal cell-derived factor-1 on the migration and localization of precursor-B acute lymphoblastic leukemia cells within bone marrow stromal layers.
Bradstock KF; Makrynikola V; Bianchi A; Shen W; Hewson J; Gottlieb DJ
Leukemia; 2000 May; 14(5):882-8. PubMed ID: 10803521
[TBL] [Abstract][Full Text] [Related]
14. CXCR4-mediated bone marrow progenitor cell maintenance and mobilization are modulated by c-kit activity.
Cheng M; Zhou J; Wu M; Boriboun C; Thorne T; Liu T; Xiang Z; Zeng Q; Tanaka T; Tang YL; Kishore R; Tomasson MH; Miller RJ; Losordo DW; Qin G
Circ Res; 2010 Oct; 107(9):1083-93. PubMed ID: 20847314
[TBL] [Abstract][Full Text] [Related]
15. Integrin alpha4beta1 involvement in stromal cell-derived factor-1alpha-promoted myeloma cell transendothelial migration and adhesion: role of cAMP and the actin cytoskeleton in adhesion.
Parmo-Cabañas M; Bartolomé RA; Wright N; Hidalgo A; Drager AM; Teixidó J
Exp Cell Res; 2004 Apr; 294(2):571-80. PubMed ID: 15023543
[TBL] [Abstract][Full Text] [Related]
16. The chemokine receptor CXCR4 enhances integrin-mediated in vitro adhesion and facilitates engraftment of leukemic precursor-B cells in the bone marrow.
Shen W; Bendall LJ; Gottlieb DJ; Bradstock KF
Exp Hematol; 2001 Dec; 29(12):1439-47. PubMed ID: 11750103
[TBL] [Abstract][Full Text] [Related]
17. CXCR4-targeted PET imaging using
Muz B; Bandara N; Mpoy C; Sun J; Alhallak K; Azab F; Rogers BE; Azab AK
Cancer Biol Ther; 2020; 21(1):52-60. PubMed ID: 31571524
[No Abstract] [Full Text] [Related]
18. Targeting survival and cell trafficking in multiple myeloma and Waldenstrom macroglobulinemia using pan-class I PI3K inhibitor, buparlisib.
Sahin I; Azab F; Mishima Y; Moschetta M; Tsang B; Glavey SV; Manier S; Zhang Y; Sacco A; Roccaro AM; Azab AK; Ghobrial IM
Am J Hematol; 2014 Nov; 89(11):1030-6. PubMed ID: 25060991
[TBL] [Abstract][Full Text] [Related]
19. Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells.
Kijima T; Maulik G; Ma PC; Tibaldi EV; Turner RE; Rollins B; Sattler M; Johnson BE; Salgia R
Cancer Res; 2002 Nov; 62(21):6304-11. PubMed ID: 12414661
[TBL] [Abstract][Full Text] [Related]
20. CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy.
Azab AK; Runnels JM; Pitsillides C; Moreau AS; Azab F; Leleu X; Jia X; Wright R; Ospina B; Carlson AL; Alt C; Burwick N; Roccaro AM; Ngo HT; Farag M; Melhem MR; Sacco A; Munshi NC; Hideshima T; Rollins BJ; Anderson KC; Kung AL; Lin CP; Ghobrial IM
Blood; 2009 Apr; 113(18):4341-51. PubMed ID: 19139079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]